Literature DB >> 14675629

Alterations in HIV-1 LTR promoter activity during AIDS progression.

Kirsten Hiebenthal-Millow1, Thomas C Greenough, Doreen B Bretttler, Michael Schindler, Steffen Wildum, John L Sullivan, Frank Kirchhoff.   

Abstract

HIV-1 variants evolving in AIDS patients frequently show increased replicative capacity compared to those present during early asymptomatic infection. It is known that late stage HIV-1 variants often show an expanded coreceptor tropism and altered Nef function. In the present study we investigated whether enhanced HIV-1 LTR promoter activity might also evolve during disease progression. Our results demonstrate increased LTR promoter activity after AIDS progression in 3 of 12 HIV-1-infected individuals studied. Further analysis revealed that multiple alterations in the U3 core-enhancer and in the transactivation-response (TAR) region seem to be responsible for the enhanced functional activity. Our findings show that in a subset of HIV-1-infected individuals enhanced LTR transcription contributes to the increased replicative potential of late stage virus isolates and might accelerate disease progression.

Entities:  

Mesh:

Year:  2003        PMID: 14675629     DOI: 10.1016/j.virol.2003.08.034

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression.

Authors:  Eva Ramírez de Arellano; Cristina Martín; Vincent Soriano; José Alcamí; Africa Holguín
Journal:  Virus Genes       Date:  2006-12-09       Impact factor: 2.332

Review 2.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

3.  Evidences for viral strain selection in late stages of HIV infection: an analysis of Vpu alleles.

Authors:  Marcos Vinícius Pereira Gondim; Joaquim Xavier da Silva; Francisco Prosdocimi; Eduardo Leonardecz-Neto; Octávio Luiz Franco; Enrique Roberto Argañaraz
Journal:  Protein J       Date:  2012-02       Impact factor: 2.371

4.  Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Evelyn Regina de Souza Pastena; Walter Kleine Neto; Vanessa Pouza Martinez; Ester Cerdeira Sabino
Journal:  Virol J       Date:  2010-04-16       Impact factor: 4.099

5.  Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.

Authors:  B Murphy; C Hillman; S McDonnel
Journal:  Virus Res       Date:  2013-11-28       Impact factor: 3.303

6.  BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex.

Authors:  Valeriu B Cismasiu; Elena Paskaleva; Sneha Suman Daya; Mario Canki; Karen Duus; Dorina Avram
Journal:  Virology       Date:  2008-09-02       Impact factor: 3.616

7.  Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression.

Authors:  Roshni Mehta; Vasudha Sundaravaradan; Nafees Ahmad
Journal:  Virology       Date:  2008-03-03       Impact factor: 3.616

Review 8.  Genetic architecture of HIV-1 genes circulating in north India & their functional implications.

Authors:  Ujjwal Neogi; Vikas Sood; Larence Ronsard; Jyotsna Singh; Sneh Lata; V G Ramachandran; S Das; Ajay Wanchu; Akhil C Banerjea
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 9.  Viral determinants of HIV-1 macrophage tropism.

Authors:  Christopher J A Duncan; Quentin J Sattentau
Journal:  Viruses       Date:  2011-11-15       Impact factor: 5.048

10.  Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site.

Authors:  Yujie Liu; Michael R Nonnemacher; Aikaterini Alexaki; Vanessa Pirrone; Anupam Banerjee; Luna Li; Evelyn Kilareski; Brian Wigdahl
Journal:  Clin Med Insights Pathol       Date:  2017-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.